Enterprise AI spending is moving from experimentation to scrutiny. After two years of heavy investment, boards are demanding evidence that AI portfolios deliver measurable returns - and vendors that can't prove their value face a sharp correction over the next 12 to 18 months.
The shift is visible in what executives now track. A recent study found that revenue growth and profitability improvement are the primary ROI metrics for AI projects, selected by 22% of respondents, ahead of productivity at 18%. That focus on the bottom line reflects the scale of commitment: BCG figures put average AI spend this year at 1.7% of revenues, with some businesses supporting AI portfolios worth up to five points of EBITDA. At that level, AI is no longer an innovation budget line. It is balance sheet exposure, and boards are treating it accordingly.
The AltaVista trap
The market is not evolving incrementally. Platforms are overtaking one another in capability, cost-efficiency and architecture at a pace that enterprise procurement cycles were never designed to track. A leading tool in any given category today may occupy a distant second position within 90 days. These are not marginal improvements but structural shifts in underlying model capability, reasoning depth or integration architecture that render yesterday's best answer genuinely obsolete.
History offers a warning. AltaVista was an early leader in web search with a strong user base, yet it lost to Google, a newcomer that learned where the pioneers were going wrong and overtook them through rapid technological advancement. Many current AI leaders risk being leapfrogged the same way - and the environment is more perilous now than it was in the mid-'90s because AI technology is evolving faster than anything that has come before.
For enterprise IT users, this creates a strategic trap. A standard software evaluation - RFP, shortlist, proof of concept, legal review, contract - can consume six to nine months. In AI terms, that is two or three capability generations. Businesses that standardize too early risk being locked into a platform that's soon out of date. Delaying key decisions carries its own risk: missing the productivity gains competitors are already realizing.
The best course is to track the market closely without over-committing. That means carrying out regular technology evaluations while keeping options open across two or three platforms, and resisting vendor pressure to sign long-term contracts for platforms still in development. Vendors pressing hardest for long-term commitment are often the ones with the most to lose if you wait.
Where clear leaders have emerged
There is one major caveat. In a few niche areas, a clear leader has already emerged - the Google to the AltaVistas of this world - and the gap is so large it's unlikely to be closed anytime soon. In those cases, businesses can invest with much greater confidence.
Developer tooling is the clearest example. "Claude Code outperformed everything else we tested, and the margin was not close enough to generate any real debate," said one evaluation across every serious option for AI-assisted coding. "For our developers, Claude Code is so dominant there's no point in maintaining Gemini or OpenAI licences, and we've therefore been able to benefit from cost consolidation."
That kind of clarity is useful, and organizations should act on it where they find it. The mistake is assuming that because one category has settled, the others have too. In areas like AI-assisted design, marketing content generation and enterprise search, the picture remains genuinely unsettled, and standardizing now carries real risk.
What consolidation will look like
The AI tools that survive the coming reckoning share three characteristics: they are deeply embedded in workflows rather than sitting alongside them; they deliver measurable, attributable outcomes rather than general productivity improvements that are hard to isolate; and they serve use cases where the switching cost is high enough that users do not migrate the moment a competitor releases an update.
Tools that fail those tests - particularly ones that gained traction because they had no good alternative in 2023 rather than because they were genuinely superior - will face a sharp correction. Some will be acquired for their user bases or technical teams. Others will simply lose enterprise renewals at a rate that's not sustainable.
Organizations best placed to navigate this period will have maintained honest internal records of what value their AI investments deliver. Success will be quantifiable through gains in output, quality or cost at a team or process level - not measured by anecdotal evidence from enthusiastic early adopters. That discipline is harder to maintain during experimentation, but it separates organizations that will make smart consolidation decisions from those that will cut platforms indiscriminately when pressure arrives.
What to do now
Three steps matter as organizations review their AI investment strategy.
First, resist multi-year platform agreements in categories where the technology is still visibly moving. Negotiate annual terms where possible and insist on contractual clarity around capability benchmarks and data portability. If a vendor will not agree to data export provisions, treat that as a significant red flag.
Second, document what AI tools are producing in terms that will survive a CFO's scrutiny. That means outcome metrics tracked at the team or process level, not survey-based satisfaction scores or anecdotal reports. If you cannot produce this data today, instrument for it now, before the renewal conversation begins. This is where an AI Learning Path for CFOs can help finance leaders establish the right measurement frameworks. For broader guidance on investment decisions, resources on AI for Executives & Strategy cover how leadership teams evaluate AI portfolios under financial scrutiny.
Third, move decisively in categories where consolidation has already happened. Where a clear leader has emerged and the capability gap is structural rather than marginal, consolidating onto that platform and removing competing licences is straightforward value capture. The cost savings fund the optionality you need to maintain elsewhere.
Why this matters for executives and strategy
When your board asks what the company is spending on AI, walk in with two numbers: what you are spending, and what you are getting. Organizations that cannot produce the second number will be cutting indiscriminately in 18 months. The ones that can will compound the advantage they have already built.
The AI Leapfrog Effect is not a reason for paralysis. It is a call for precision: know where the market has settled, know where it has not, and build your investment strategy around that distinction rather than around vendor timelines or the anxiety of being left behind. In AI, selective standardization is a virtue. Premature standardization is a liability. The organizations that internalize this will not just survive the consolidation wave but define the competitive landscape on the other side of it.
Your membership also unlocks:
